• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500400-23
Device Problem Material Separation (1562)
Patient Problem Foreign Body In Patient (2687)
Event Date 03/12/2023
Event Type  Death  
Event Description
It was reported that on (b)(6) 2023, the patient presented with intermittent chest pain and a 4.0x23mm xience sierra stent delivery system (sds) was implanted in left anterior descending artery (lad).The patient was noted to be asymptomatic and discharged two days later.On (b)(6) 2023, the patient suffered a cardiac arrest, cpr was performed by the paramedics and intermittent restoration of circulation and blood pressure was obtained.However, during transit to the hospital the patient expired.Autopsy revealed a large recent myocardial infraction in the anterior wall of the left ventricle and adjacent interventricular septum.It was noted that the xience stent was patient; however, there was significant atherosclerotic stenosis of the lad distal to the stent.In a small intramyocardial artery, a small non-metallic stent matrix material (possibly the tip of a delivery catheter) was found and some macrophages were surrounding it.Cause of death was noted to be due to complication of recent massive myocardial infarction.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported material separation.Factors that may contribute to material separation include, but are not limited to, interaction with challenging anatomy, interaction with accessory devices, manipulation against resistance, or excessive force applied to device.The separated portion of the stent delivery system was discovered in the patient¿s anatomy during the autopsy.The cause of death was attributed to complications of recent massive myocardial infarction (mi).The reported patient effect of death is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling.A medical review was performed.The reviewer stated ¿the most likely cause of death is the large anterior wall mi in the lad and the relationship of the non-metallic stent material within the intramyocardial arteries may have contributed to atherosclerotic plaque formation proximal to the artery that could have occluded the vessel and cascaded to thrombosis which eventually led to the myocardial infarction.As the device was discarded, the relationship of the nonmetallic material to the xience stent delivery system cannot be fully established.¿ b2, h1: death added.
 
Event Description
Based on the investigation, the most likely cause of death is the large anterior wall myocardial infarction in the lad and the relationship of the non-metallic stent material within the intramyocardial arteries may have contributed to atherosclerotic plaque formation proximal to the artery that could have occluded the vessel and cascaded to thrombosis which eventually led to the myocardial infarction.As the device was discarded, the relationship of the nonmetallic material to the xience stent delivery system cannot be fully established; however, this will conservatively be filed as a death.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17319106
MDR Text Key319019694
Report Number2024168-2023-07487
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1500400-23
Device Lot Number1063041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Death;
Patient Age37 YR
Patient SexMale
-
-